FindTrial
Sign In

The effect of terbutaline sulfate on the safety and effectiveness of fetal intrauterine resuscitation: a randomized controlled study

Randomized comparison of intravenous terbutaline vs nifedipine for acute intrapartum fetal resuscitation

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100047370
Enrollment
Unknown
Registered
2021-06-13
Start date
2021-06-01
Completion date
Unknown
Last updated
2022-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute fetal distress

Interventions

Group A:subcutaneous terbutaline 0.25 mg
Group B:oral nifedipine 10 mg

Sponsors

Guangzhou Women and Children's Medical Center
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Frequent contractions or forced contractions occur during labor; 2. Unreliable fetal monitoring appears; 3. The basal heart rate of pregnant women is less than 110bpm.

Exclusion criteria

Exclusion criteria: Can not cooperate with intervention and curative effect observation.

Design outcomes

Primary

MeasureTime frame
the success rate of intrauterine resuscitation;the time of drug onset;—

Countries

China

Contacts

Public ContactZheng Zheng

Guangzhou Women and Children's Medical Center

libra2046@126.com+86 13632311057

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026